Group of medical professionals

Scientific Congresses in Neuroscience

Scientific Congresses and Resources

This is not intended to be a comprehensive resource of all congresses and congress materials across therapeutic and disease areas. Congress materials may include information about investigational use(s) of compounds/products that are not approved for use by the U.S. Food and Drug Administration (FDA) and/or are inconsistent with the Prescribing Information. Takeda does not recommend the use of any Takeda product beyond the approved labeling. Any decisions regarding the usage of a Takeda product beyond the approved labeling are left to the discretion of the healthcare professional. Takeda makes no representations about whether investigational compounds or unapproved uses will be approved by the FDA.

Psych Congress (Psych Congress), 2025

September 17 - 21, 2025

Psych Congress is the nation's leading conference on practical psychopharmacology.

Trintellix® (vortioxetine)

  • Impact of Antidepressants on the Longitudinal Evolution of Major Depressive Disorder Symptomatology
    View PDF
  • Patient-Defined Goal Attainment and Progress in the PatientsLikeMe (PLM) Community: Insights From a Longitudinal, Quantitative, Decentralized Study Using the PLM Platform
    View PDF
  • Antidepressant Treatment Patterns Among Patients With Depression: A Retrospective, Longitudinal Analysis of US Health Insurance Claims and Electronic Health Record Data
    View PDF
  • Prevalence of Residual Symptoms in Adults With Depression or Major Depressive Disorder on Antidepressant Monotherapy: A Retrospective, Longitudinal Analysis of US Health Insurance Claims and Electronic Health Record Data
    View PDF

American Academy of Sleep Medicine (SLEEP), 2025

June 8 - 11, 2025

Annual meeting of the Associated Professional Sleep Societies, LLC (APSS), which is a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS).

American Society of Clinical Psychopharmacology (ASCP), 2025

May 27 - 30, 2025

Annual meeting bringing perspectives together from academia, NIH, FDA, clinicians and industry on key aspects of neuropsychiatric drug development, pharmacogenetics and personalized interventions.

Trintellix® (vortioxetine)

  • Real-World Practice Patterns and Outcomes in Patients With Major Depressive Disorder Treated With Antidepressants
    View PDF

American Academy of Neurology (AAN), 2025

April 5 - 9, 2025

Annual meeting in neurology promoting high quality patient-centric care in a variety of topics and specialties through various learning formats.

American Epilepsy Society (AES), 2024

December 6 - 10, 2024

Annual Meeting brings together healthcare providers, scientists, advocates, industry, and other professionals dedicated to better outcomes for people with epilepsy.

U.S. Psychiatric and Mental Health Congress (US Psych), 2024

October 29 - November 2, 2024

National congress on practical psychopharmacology focused on practical, real-world training, covering the latest techniques, treatments, best practices, and evidence-based care.

Trintellix® (vortioxetine)

  • Antidepressant Changes and App Usage Improve MDD Outcomes in Study to Implement the Pathway Platform in Primary Care: A Post Hoc Subgroup Analysis
    View PDF
  • Noninterventional, Retrospective, Prospective, Longitudinal Cohort Study to Assess Antidepressant Treatment Patterns and Outcomes in Individuals With Major Depressive Disorder
    View PDF
  • 24-Week Results From a PatientsLikeMe Observational Study: Vortioxetine vs Standard of Care Antidepressants in Major Depressive Disorder
    View PDF